Padmini KAVURU
11Patents
3h-index
15Co-inventors
53Inventor score
Filing activity: Mar 26, 2012 → Apr 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10376521B2 | Nutraceutical co-crystal compositions | Chemistry; Metallurgy | 12 | Active |
| US9884813B1 | Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US9827217B2 | Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof | Human Necessities | 7 | Active |
| US10842797B2 | Nutraceutical co-crystal compositions | Chemistry; Metallurgy | 1 | Active |
| US10196355B2 | Forms of apremilast | Chemistry; Metallurgy | 1 | Active |
| US10730836B2 | Forms of apremilast | Chemistry; Metallurgy | 0 | Active |
| US11535644B2 | Solid-state forms of Regadenoson, their use and preparation | Chemistry; Metallurgy | 0 | Active |
| US11524953B2 | Niraparib solid state form | Chemistry; Metallurgy | 0 | Active |
| US10512623B2 | Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof | Human Necessities | 0 | Active |
| US10130708B2 | Lithium cocrystal compositions | Human Necessities | 0 | Active |
| US11440908B2 | Crystalline forms of dasatinib | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.